PAPER
Ring Opening of Epoxides and Aziridines with Sodium Azide
2257
1H NMR (200 MHz, CDCl3): = 1.55 (br s, 1 H, OH), 3.70 (d,
1N-[2-Azido-2-(4-methylphenyl)ethyl]-4-methyl-1-benzene-
J = 6.5 Hz, 2 H, CH N ), 4.20 (d, J = 6.5 Hz, 2 H, OCH ), 4.65 (t,
sulfonamide (Table 2, Entry 2)
2
3
2
J = 6.5 Hz, 1 H, CHOH), 7.20–7.40 (m, 5 H, ArH).
Liquid.
MS (EI): m/z = 192 (M – 1)+.
IR (neat): 2100, 3370 cm–1.
1H NMR (200MHz, CDCl3): = 2.35 (s, 3 H, ArCH ), 2.45 (s, 3 H,
3
1
1
-Azido-3-(3,5-dimethylphenoxy)-2-propanol (Table 1, Entry
0)
ArCH ), 2.94–3.30 (m, 2 H, CH N ), 4.50–4.60 (dd, J = 7.8, 5.2 Hz,
3
2
3
1
H, CHNH), 4.90 (m, 1 H, NH), 7.10–7.20 (m, 4 H, ArH), 7.30 (d,
Liquid.
J = 8.4 Hz, 2 H, ArH), 7.75 (d, J = 8.4 Hz, 2 H, ArH).
–
1
IR (neat): 2100, 3390 cm .
1H NMR (200 MHz, CDCl3): = 1.48 (br s, 1 H, OH), 2.30 (s, 6 H,
+
MS (EI): m/z = 288 (M – N ) .
3
ArCH ), 3.50 (dd, J = 4.2, 4.6 Hz, 2 H, NCH ), 4.00 (d, J = 6.5 Hz,
1N-[2-Azido-1-(4-methylphenyl)ethyl]-4-methyl-1-benzene-
3
2
2
1
H, OCH ), 4.05–4.20 (m, 1 H, OCH), 6.55 (s, 2 H, ArH), 7.00 (s,
H, ArH).
sulfonamide
2
1
H NMR (200 MHz, CDCl3): = 2.30 (s, 3 H, ArCH ), 2.40 (s, 3 H,
3
MS (EI): m/z = 220 (M – 1)+.
ArCH
3
), 3.49 (d, J = 5.6 Hz, 2 H, CH
2 3
N ), 4.35–4.40 (dd, J = 11.8,
5
7
.6 Hz, 1 H, CHNH), 5.20 (m, 1 H, NH), 7.00–7.15 (m, 4 H, ArH),
.25 (d, J = 8.0 Hz, 2 H, ArH), 7.65 (d, J = 8.0 Hz, 2 H, ArH).
N-[2-Azido-2-(4-chlorophenyl)ethyl]-4-methyl-1-benzene-
1
1
-Azido-3-(3,5-dichlorophenoxy)-2-propanol (Table 1, Entry
1)
1
Liquid.
sulfonamide (Table 2, Entry 3)
IR (neat): 2100, 3390 cm .
1H NMR (200 MHz, CDCl3): = 2.45 (s, 3 H, ArCH ), 3.05–3.15
–
1
IR (neat): 2100, 3555 cm .
–1
1
H NMR (200MHz, CDCl3):
= 2.75 (br s, 1 H, OH), 3.80 (t,
3
J = 7.2 Hz, 2 H, CH N ), 4.12 (d, J = 6.8 Hz, 2 H, OCH ), 4.15–4.30
2
3
2
(m, 1 H), 3.15–3.30 (m, 1 H), 4.55–4.60 (dd, J = 11.9, 5.9 Hz, 1 H,
CHNH), 4.90 (m, 1 H, NH), 7.00–7.15 (m, 4 H, ArH), 7.35 (d,
J = 8.0 Hz, 2 H, ArH), 7.80 (d, J = 8.0 Hz, 2 H, ArH).
+
(m, 1 H, CHOH), 6.86 (m, 1 H, ArH), 7.21 (m, 1 H, ArH), 7.38 (m,
1
H, ArH).
MS (EI): m/z = 261 (M – 1)+.
MS (EI): m/z = 308 (M – N ) .
3
1
-Azido-3-(2-naphthyloxy)-2-propanol (Table 1, Entry 12)
1
N-[2-Azido-1-(4-chlorophenyl)ethyl]-4-methyl-1-benzene-
sulfonamide
IR (neat): 2100, 3280 cm .
Liquid.
–
1
–
1
IR (neat): 2100, 3385 cm .
1H NMR (200 MHz, CDCl3): = 2.50 (br s, 1 H, OH), 3.55 (t,
J = 4.6 Hz, 1 H, CHN ), 3.85 (t, J = 6.4 Hz, 1 H, CHN ), 4.10 (d,
J = 6.5 Hz, 2 H, OCH ), 4.15–4.27 (m, 1 H, CHOH), 7.05–7.15 (m,
1H NMR (200 MHz, CDCl3): = 2.40 (s, 3 H, ArCH ), 3.45–3.55
3
(
(
m, 2 H, CH N ), 4.40–4.50 (dd, J = 8.9, 5.1 Hz, 1 H, CHNH), 5.20
m, 1 H, NH), 7.10–7.20 (m, 4 H, ArH), 7.30 (d, J = 8.2 Hz, 2 H,
2 3
3
3
2
ArH), 7.75 (d, J = 8.1 Hz, 2 H, ArH).
2
H, ArH), 7.25–7.45 (m, 2 H, ArH), 7.65–7.80 (m, 3 H, ArH).
+
MS (EI): m/z = 242 (M – 1)+.
MS (EI): m/z = 308 (M – N ) .
3
1
N–(2-Azido-1-cyclohexylethyl)-4-methyl-1-benzenesulfona-
1
-Azido-3-[3-phenyl-(E)-2-propenyloxy]-2-propanol (Table 1,
mide (Table 2, Entry 4)
Liquid.
Entry 13)
Liquid.
–
1
–
1
IR (neat): 2100, 3380 cm .
IR (neat): 2100, 3390 cm .
1H NMR (200 MHz, CDCl3): = 0.60–1.80 (m, 1 H, cyclohexyl),
1H NMR (200 MHz, CDCl3): = 2.45 (br s, 1 H, OH), 3.39 (dd, 2
2
1
.40 (s, 3 H, CH ), 3.26 (dd, 1 H, J = 3.2, 9.4 Hz, CH N ), 3.30 (dd,
H, J = 2.9, 5.9 Hz, CH N ), 3.49–3.57 (m, 2 H, OCH ), 3.92–3.99
3
2
3
2
3
2
H, J = 3.2, 9.4 Hz, CH N ), 5.20 (m, 1 H, NH), 7.30 (d, J = 7.5 Hz,
(
(
m, 1 H, CHOH), 4.21 (dd, 2 H, J = 1.0, 6.1 Hz, OCH ), 6.20–6.30
m, 1 H, olefinic), 6.60 (d, 1 H, J = 15.9 Hz, olefinic), 7.22–7.42 (m,
2
3
2
ArH), 7.80 (d, J = 7.5 Hz, ArH).
5
H, ArH).
+
MS (EI): m/z = 101 (M – CH N ) .
2
3
MS (EI): m/z = 160 (M – 1)+.
N-(2-Azidocyclohexyl)-4-methylbenzenesulfonamide (Table 2,
Entry 5)
Liquid.
IR (neat): 2100, 3320 cm–1.
1
(
N-(2-Azido-2-phenyethyl)-4-methyl-1-benzenesulfonamide
Table 2, Entry 1)
Liquid.
–
1
IR (neat): 2100, 3270 cm .
1H NMR (200 MHz, CDCl3): = 2.45 (s, 3 H, ArCH ), 2.95–3.10
1
H NMR (400 MHz, CDCl ): = 1.20–1.40 (m, 4 H), 1.60–1.75 (m,
3
2 H), 2.00–2.15 (m, 2 H), 2.45 (s, 3 H, ArCH ), 2.85–2.95 (m, 1 H,
3
3
CHN ), 3.00–3.10 (m, 1 H, CHNH), 4.80 (d, J = 5.4 Hz, 1 H, NH),
(m, 1 H, CHNH), 3.10–3.30 (m, 1 H, CHNH), 4.55–4.65 (dd,
3
7
.30 (d, J = 8.1 Hz, 2 H, ArH), 7.80 (d, J = 8.1 Hz, 2 H, ArH).
J = 7.7, 5.0 Hz, 1 H, CHN ), 5.30–5.50 (m, 1 H, NH), 7.05–7.40 (m,
3
7
H, ArH), 7.75 (d, J = 8.0 Hz, 2 H, ArH).
MS (EI): m/z = 294 (M+).
+
MS (EI): m/z = 274 (M – N ) .
3
N-(2-Azidocyclopentyl)-4-methylbenzenesulfonamide (Table 2,
Entry 6)
Liquid.
1
N-(2-Azido-1-phenylethyl)-4-methyl-1-benzenesulfonamide
1
H NMR (200 MHz, CDCl3): = 2.40 (s, 3 H, ArCH ), 3.35–3.55
3
(
d, J = 5.6 Hz, 2 H, CH N ), 4.70–4.85 (dd, J = 11.8, 5.5 Hz, 1 H,
IR (neat): 2105, 3270 cm–1.
2
3
CHNH), 5.65–5.75 (m, 1 H, NH), 7.10–7.40 (m, 7 H, ArH), 7.60 (d,
J = 8.0 Hz, 2 H, ArH).
1
H NMR (400 MHz, CDCl ): = 1.30–1.50 (m, 1 H), 1.60–1.75 (m,
3
3
H), 1.95–2.10 (m, 2 H), 2.45 (s, 3 H, ArCH ), 3.30–3.50 (m, 1 H,
3
Synthesis 2002, No. 15, 2254–2258 ISSN 0039-7881 © Thieme Stuttgart · New York